Magnolol, a natural compound, induces apoptosis of SGC-7901 human gastric adenocarcinoma cells via the mitochondrial and PI3K/Akt signaling pathways

International Journal of Oncology

Volumn 40, Issue 4, 2012, Pages 1153-1161

  Rasul, Azhar ^a   Yu, Bo ^b   Khan, Muhammad ^a   Zhang, Kun ^a   Iqbal, Furhan ^c   Ma, Tonghui ^a,b   Yang, Hong ^b  

^a THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^b LIAONING NORMAL UNIVERSITY   (China)

^c BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

Author keywords

Apoptosis; Magnolol; Natural compounds; S phase arrest; SGC 7901 cells

Indexed keywords

CASPASE 3; MAGNOLOL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B;

APOPTOSIS; ARTICLE; AUTOPHAGY; CARCINOMA CELL; CELL CYCLE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BIPHENYL COMPOUNDS; CASPASE 3; CELL GROWTH PROCESSES; DOWN-REGULATION; ENZYME ACTIVATION; HUMANS; LIGNANS; MITOCHONDRIA; PHOSPHATIDYLINOSITOL 3-KINASES; PLATELET AGGREGATION INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2; S PHASE; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84863337524     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1277     Document Type: Article

References (64)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Hernandez BY, Green MD, Cassel KD, Pobutsky AM, Vu V and Wilkens LR: Preview of Hawaii Cancer Facts and Figures 2010. Hawaii Med J 69: 223-224, 2010.
3. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
4. Yang L, Parkin DM, Ferlay J, Li L and Chen Y: Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14: 243-250, 2005. (Pubitemid 40165308)
5. Roth AD: Curative treatment of gastric cancer: towards a multidisciplinary approach? Crit Rev Oncol Hematol 46: 59-100, 2003.
6. Amin AR, Kucuk O, Khuri FR and Shin DM: Perspectives for cancer prevention with natural compounds. J Clin Oncol 27: 2712-2725, 2009.
7. Cragg GM and Newman DJ: Plants as a source of anti-cancer agents. J Ethnopharmacol 100: 72-79, 2005. (Pubitemid 41073525)
8. Gordaliza M: Natural products as leads to anticancer drugs. Clin Transl Oncol 9: 767-776, 2007.
9. Fujita S and Taira J: Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102. Free Radic Biol Med 17: 273-277, 1994. (Pubitemid 24269680)
10. Kong CW, Tsai K, Chin JH, Chan WL and Hong CY: Magnolol attenuates peroxidative damage and improves survival of rats with sepsis. Shock 13: 24-28, 2000.
11. Lee YM, Hsiao G, Chen HR, Chen YC, Sheu JR and Yen MH: Magnolol reduces myocardial ischemia/reperfusion injury via neutrophil inhibition in rats. Eur J Pharmacol 422: 159-167, 2001. (Pubitemid 32595587)
12. Teng CM, Ko FN, Wang JP, et al: Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbs. J Pharm Pharmacol 43: 667-669, 1991.
13. Ho KY, Tsai CC, Chen CP, Huang JS and Lin CC: Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Phytother Res 15: 139-141, 2001.
14. Hamasaki Y, Kobayashi I, Zaitu M, et al: Magnolol inhibits leukotriene synthesis in rat basophilic leukemia-2H3 cells. Planta Med 65: 222-226, 1999. (Pubitemid 29186074)
15. Bang KH, Kim YK, Min BS, et al: Antifungal activity of magnolol and honokiol. Arch Pharm Res 23: 46-49, 2000.
16. Wang JP, Hsu MF, Raung SL, Chen CC, Kuo JS and Teng CM: Anti-inflammatory and analgesic effects of magnolol. Naunyn Schmiedebergs Arch Pharmacol 346: 707-712, 1992.
17. Chang WS, Chang YH, Lu FJ and Chiang HC: Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res 14: 501-506, 1994.
18. Ikeda K, Sakai Y and Nagase H: Inhibitory effect of magnolol on tumour metastasis in mice. Phytother Res 17: 933-937, 2003. (Pubitemid 37152762)
19. Konoshima T, Kozuka M, Tokuda H, et al: Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis. J Nat Prod 54: 816-822, 1991.
20. Kuo DH, Lai YS, Lo CY, Cheng AC, Wu H and Pan MH: Inhibitory effect of magnolol on TPA-induced skin inflammation and tumor promotion in mice. J Agric Food Chem 58: 5777-5783, 2010.
21. You Q, Li M and Jiao G: Magnolol induces apoptosis via activation of both mitochondrial and death receptor pathways in A375-S2 cells. Arch Pharm Res 32: 1789-1794, 2009.
22. Hsu YF, Lee TS, Lin SY, et al: Involvement of Ras/Raf-1/ERK actions in the magnolol-induced upregulation of p21 and cell-cycle arrest in colon cancer cells. Mol Carcinog 46: 275-283, 2007.
23. Lee SK, Kim HN, Kang YR, et al: Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis. Bioorg Med Chem 16: 8397-8402, 2008.
24. Lin SY, Chang YT, Liu JD, et al: Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells. Mol Carcinog 32: 73-83, 2001.
25. Lin SY, Liu JD, Chang HC, Yeh SD, Lin CH and Lee WS: Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis. J Cell Biochem 84: 532-544, 2002. (Pubitemid 34111187)
26. Hwang ES and Park KK: Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in PC-3 human prostate carcinoma cells. Biosci Biotechnol Biochem 74: 961-967, 2010.
27. Lee DH, Szczepanski MJ and Lee YJ: Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. J Cell Biochem 106: 1113-1122, 2009.
28. Chen LC, Liu YC, Liang YC, Ho YS and Lee WS: Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21/Cip1. J Agric Food Chem 57: 7331-7337, 2009.
29. 2+ mobilization in rat cortical neurons and human neuroblastoma SH-SY5Y cells. Eur J Pharmacol 474: 199-204, 2003.
30. Li HB, Yi X, Gao JM, Ying XX, Guan HQ and Li JC: Magnolol-induced H460 cells death via autophagy but not apoptosis. Arch Pharm Res 30: 1566-1574, 2007.
31. Yang SE, Hsieh MT, Tsai TH and Hsu SL: Effector mechanism of magnolol-induced apoptosis in human lung squamous carcinoma CH27 cells. Br J Pharmacol 138: 193-201, 2003.
32. Syu WJ, Shen CC, Lu JJ, Lee GH and Sun CM: Antimicrobial and cytotoxic activities of neolignans from Magnolia officinalis. Chem Biodivers 1: 530-537, 2004.
33. Huang SH, Chen Y, Tung PY, et al: Mechanisms for the magnolol-induced cell death of CGTH W-2 thyroid carcinoma cells. J Cell Biochem 101: 1011-1022, 2007. (Pubitemid 47040881)
34. Nagase H, Ikeda K and Sakai Y: Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro. Planta Med 67: 705-708, 2001. (Pubitemid 33044474)
35. KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells. Biochem Pharmacol 75: 2289-2300, 2008.
36. Lee SJ, Park SS, Lee US, Kim WJ and Moon SK: Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells. Int Immunopharmacol 8: 1821-1826, 2008.
37. Rasul A, Khan M, Yu B, Ma T and Yang H: Xanthoxyletin, a coumarin induces S phase arrest and apoptosis in human gastric adenocarcinoma SGC-7901 cells. Asian Pac J Cancer Prev 12: 1219-1223, 2011.
38. Kanzawa T, Kondo Y, Ito H, Kondo S and Germano I: Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res 63: 2103-2108, 2003. (Pubitemid 36538613)
39. Levine B and Yuan J: Autophagy in cell death: an innocent convict? J Clin Invest 115: 2679-2688, 2005. (Pubitemid 41434392)
40. Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y and Kondo S: Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 24: 980-991, 2005. (Pubitemid 40313875)
41. Li DD, Guo JF, Huang JJ, et al: Rhabdastrellic acid-A induced autophagy-associated cell death through blocking Akt pathway in human cancer cells. PLoS One 5: e12176, 2010.
42. King KL and Cidlowski JA: Cell cycle regulation and apoptosis. Annu Rev Physiol 60: 601-617, 1998. (Pubitemid 28157888)
43. Pan J, She M, Xu ZX, Sun L and Yeung SC: Farnesyltransferase inhibitors induce DNA damage via reactive oxygen species in human cancer cells. Cancer Res 65: 3671-3681, 2005. (Pubitemid 40616344)
44. Grana X and Reddy EP: Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11: 211-219, 1995.
45. Kastan MB, Canman CE and Leonard CJ: P53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 14: 3-15, 1995.
46. Pavletich NP: Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol 287: 821-828, 1999.
47. Mantena SK, Sharma SD and Katiyar SK: Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 5: 296-308, 2006.
48. Srivastava JK and Gupta S: Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem Biophys Res Commun 346: 447-453, 2006. (Pubitemid 43902706)
49. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
50. Zhou HB and Zhu JR: Paclitaxel induces apoptosis in human gastric carcinoma cells. World J Gastroenterol 9: 442-445, 2003.
51. Olson M and Kornbluth S: Mitochondria in apoptosis and human disease. Curr Mol Med 1: 91-122, 2001.
52. Kroemer G: Mitochondrial control of apoptosis: an introduction. Biochem Biophys Res Commun 304: 433-435, 2003.
53. Huang M, Camara AK, Stowe DF, Qi F and Beard DA: Mito-chondrial inner membrane electrophysiology assessed by rhodamine-123 transport and fluorescence. Ann Biomed Eng 35: 1276-1285, 2007. (Pubitemid 46966275)
54. Porter AG and Janicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6: 99-104, 1999. (Pubitemid 29082297)
55. Mallat Z and Tedgui A: Apoptosis in the vasculature: mechanisms and functional importance. Br J Pharmacol 130: 947-962, 2000. (Pubitemid 30453528)
56. Adams JM and Cory S: The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324-1337, 2007. (Pubitemid 46328466)
57. Danial NN: BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 13: 7254-7263, 2007.
58. Han Z, Hong L, Han Y, et al: Phospho Akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax. J Exp Clin Cancer Res 26: 261-268, 2007. (Pubitemid 47025290)
59. Altomare DA and Testa JR: Perturbations of the AKT signaling pathway in human cancer. Oncogene 24: 7455-7464, 2005. (Pubitemid 41637985)
60. Lin HL, Yang MH, Wu CW, et al: 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer. Int J Cancer 121: 2547-2555, 2007.
61. Daido S, Kanzawa T, Yamamoto A, Takeuchi H, Kondo Y and Kondo S: Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res 64: 4286-4293, 2004. (Pubitemid 38802435)
62. Paglin S, Hollister T, Delohery T, et al: A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res 61: 439-444, 2001. (Pubitemid 32128593)
63. Yoshimori T: Autophagy: a regulated bulk degradation process inside cells. Biochem Biophys Res Commun 313: 453-458, 2004.
64. Eisenberg-Lerner A, Bialik S, Simon HU and Kimchi A: Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 16: 966-975, 2009.